The mechanism involved in the onset of tetracycline-induced steatosis involves the inhibition of fatty acid oxidation genes, such as PPARα, CPT1 and fatty acid binding protein 1 [74,75], and the decrease in hepatic lipoprotein secretion via microsomal triglyceride transfer protein inhibition [76,77]. The gene discussed is PPARA; the disease is steatosis.